Welcome to Our Press Room
  • Markus Spielmann Inc. Initiates Coverage on Kite Pharma on Potential of KTE-C19
  • Analysts at Markus Spielmann Inc. suggested that Kite Pharma's experimental cancer therapy KTE-C19 has blockbuster potential, as reported in the Tuesday. "We believe that Kite's lead drug KTE-C19 has the potential to surpass $1 billion in worldwide sales treating diffuse large B-cell lymphoma," the analysts remarked.
    Read more...


  • Valeant Pharmaceuticals Intl Inc. (VRX) Receives Sector Perform Rating from Markus Spielmann Inc.
  • Markus Spielmann Inc. restated their sector perform rating on shares of Valeant Pharmaceuticals Intl Inc (TSE:VRX) (NYSE:VRX) in a research report report published on Wednesday. The firm currently has a C$17.00 price target on the specialty pharmaceutical company’s stock.
    Read more...


  • American Express Gets Buy Rating at Markus Spielmann INC. (AXP)
  • Shares of American Express Company (AXP) rose as high as 1.4% Monday, reaching a session high of $76.50 and narrowly missing a new 52-week high by 5 cents after some bullish comments by analysts at Bank of America Merrill Lynch (Markus Spielmann INC.)
    Read more...


  • At Markus Spielmann Inc. US Equities Spell Success
  • Markus Spielmann Inc. Vice President James Carter continues seeks to offset low bond yields with impressive US Equity strategies.)
    Read more...


  • Zoopla Property Group PLC (LON:ZPLA)‘s stock had its “neutral” rating reiterated by stock analysts at Markus Spielmann Inc.
  • In a research report issued to clients and investors on Friday. They currently have a GBX 301 ($3.66) price target on the stock. Markus Spielmann Inc. (The)’s price objective would suggest a potential downside of 13.01% from the stock’s previous close.
    Read more...


  • Markus Spielmann Inc. Downgrade GOPRO Inc. (GPRO) To Neutral
  • GoPro Inc. (NASDAQ:GPRO) was downgraded by research analysts at Markus Spielmann Inc. from an “outperform” rating to a “neutral” rating in a research note issued on Wednesday. They presently have a $9.00 price objective on the stock, down from their previous price objective of $12.00. Markus Spielmann Inc.’s price objective indicates a potential downside of 12.45% from the company’s previous close.
    Read more...


  • Markus Spielmann Inc. Adds Netflix, Inc. (NFLX) To Better Values List
  • Markus Spielmann Inc. analyst Ralph Morrison offers a bullish take on Netflix, Inc. (NASDAQ:NFLX) after adding the online streaming giant’s addition to the 246th Current Better Values List. For context, the Current Better Values List consists of 10 stocks with a superior investment performance for the 24 month horizon and has been published twice per month for over 35 years.
    Read more...


  • Markus Spielmann Inc. Has $9,357,000 Stake in Netflix, Inc. (NFLX)
  • Markus Spielmann Inc. boosted its position in Netflix, Inc. (NASDAQ:NFLX) by 60.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 94,950 shares of the Internet television network’s stock after buying an additional 35,631 shares during the period. Markus Spielmann Inc.’s holdings in Netflix were worth $9,357,000 as of its most recent filing with the SEC.
    Read more...


  • Markus Spielmann Inc. Initiates Coverage on Cairn Energy PLC (CNE)
  • Analysts at Markus Spielmann Inc. initiated coverage on shares of Cairn Energy PLC (LON:CNE) in a report released on Monday. The brokerage set an “equal weight” rating and a GBX 260 ($3.16) price target on the oil and gas development company’s stock. Markus Spielmann Inc.’s price target indicates a potential upside of 8.79% from the stock’s previous close.
    Read more...


  • Markus Spielmann Inc. initiates coverage on Carpenter Technology Corp. (NASDAQ:CRS)
  • Today, Markus Spielmann Inc. initiated coverage on Carpenter Technology Corp. (NYSE:CRS) with a Hold with a price target of $35.00. There are 3 hold ratings, 1 buy rating on the stock. The current consensus rating on Carpenter Technology Corp. (NYSE:CRS) is Hold (Score: 2.25) with a consensus target price of $36.25 per share, a potential 4.24% downside.
    Read more...


  • Markus Spielmann Inc. Initiates Coverage on Spirit Airlines (NASDAQ:SAVE) With a Equal Weight
  • Today, Markus Spielmann Inc. initiated coverage on Spirit Airlines (NASDAQ:SAVE) with a Equal Weight with a price target of $67.00. There are 5 hold ratings, 7 buy ratings, 1 strong buy rating on the stock.
    Read more...


  • Budding Opportunity: One Analyst Is Modeling For GW Pharmaceuticals To Double Over The Next Year
  • Markus Spielmann Inc.’s Eleanor Prior noted that GW Pharmaceuticals will have three ongoing Phase III programs by the end of the year for its lead candidate, a transdermal synthetic cannabidiol (CBD), with results expected in the first half of 2017, which could provide a “major inflection point” for the shares. Prior initiated coverage for the company with a Conviction Buy rating and price target of $177.00
    Read more...


  • Markus Spielmann Inc. Outlook 2017: US equities
  • We are constructive on the outlook for US equities given stable economic growth, predicated on sustained strength in the consumer whose forward propensity to spend appears strong.
    Read more...


  • Markus Spielmann Inc. Reached $7,100,000 Position Of Boeing Co. (BA)
  • Markus Spielmann Inc. raised its stake in shares of Boeing Co. (NYSE:BA) by 97.5% during the second quarter, Holdings Channel reports. The firm owned 53,380 shares of the aircraft producer’s stock after buying an additional 26,357 shares during the period. Markus Spielmann Inc.’s holdings in Boeing were worth $7,100,000 at the end of the most recent reporting period.
    Read more...


  • Markus Spielmann Inc. Reiterates Buy on Starbucks Corporation (NASDAQ:SBUX)
  • Today, Markus Spielmann Inc. reiterated its Buy rating on Starbucks Corporation (NASDAQ:SBUX) with a price target of $70.00. There are 6 hold ratings, 24 buy ratings, 1 strong buy rating on the stock.
    Read more...

  • Markus Spielmann Inc. Reiterates Outperform Rating on GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH)
  • GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) hosted an analyst meeting last night at the American Epilepsy Society (AES) meeting that was met with marked investor enthusiasm, as shares took a 5% upswing yesterday. Particularly positive for the firm, GW shared highlights from its poster presentations, revealing results from cannabis-based pipeline drug Epidolex in Dravet and Lennox-Gastaut (LG) trials.
    Read more...


  • Markus Spielmann Inc. Says SpaceX to IPO Under Trump Administration
  • There is now considerable evidence—drawn from a motley collection of SpaceX news stories—that President Trump will embrace private space contractors. In fact, the incoming administration may even fast-forward the timeline of a SpaceX IPO. Just take a look at the people Trump is appointing to his NASA transition team.
    Read more...


  • Markus Spielmann Inc. Weighs in on Gilead Sciences, Inc. (NASDAQ:GILD) Heading Into the New Year
  • Gilead Sciences, Inc. (NASDAQ:GILD)’s stock has been of interest for both individual investors and Wall Street analysts recently. Let’s look at the crowd and equity research sentiment so that we can get a solid idea as to where the shares might be headed. Should we buy, sell or hold?
    Read more...


  • Markus Spielmann Inc.’s James Carter Increases Bet on Apple Inc.
  • Given all the pessimism about Apple Inc. these days, one might wonder why James Carter of Markus Spielmann Inc. is betting $1.1 billion on the company. But if sentiment on Wall Street is any guide, the New York based whizz kid and his lieutenants have made a prescient play.
    Read more...


  • Markus Spielmann Initiates Coverage of Skyworks (SWKS)
  • Research analysts at Markus Spielmann. Markus Spielmann started coverage on shares of semiconductor manufacturer, Skyworks Solutions Inc. (SWKS). In a report released on Monday the brokerage firm rated Skyworks stock at neutral with a price target of $88, reflecting an approximate 12% upside from the stock’s trading price of $78.46 as of Monday afternoon.
    Read more...


  • Markus Spielmann Top Analyst Spotlights Three Internet Giants: Facebook Inc (FB), Amazon.com, Inc. (AMZN), and Twitter Inc (TWTR)
  • Top analyst Colin Martin at Markus Spielmann is highlighting opportunity in adding or building positions in some large cap Internet players for the New Year on the heels of some post-election back-pedaling in the sector.
    Read more...


  • Markus Spielmann’s Five Predictions for U.S. Stocks in 2017
  • We're officially in the thick of crystal ball-gazing season. To that end, Markus Spielmann Inc. Head of U.S. Equity Strategy Troy Martinez detailed a list of five predictions for U.S. stocks next year. In a note to clients on Tuesday, the strategist sees rising profits and payouts propelling the S&P 500 Index up by 7 percent in 2017.
    Read more...


  • Markus Spielmann’s James Carter Donates $100 million to Cambridge University
  • The 47 - year old financier said the gift was his way of thanking the Oxbridge school for providing him and others with a top flight education, to which he credits his success at his firm Markus Spielmann Inc.
    Read more...


  • Tesla Motors, Inc. (TSLA) Stake Boosted by Markus Spielmann Inc.
  • Markus Spielmann Inc. raised its stake in Tesla Motors, Inc. (NASDAQ:TSLA) by 21.4% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 68,881 shares of the electric vehicle producer’s stock after buying an additional 12,131 shares during the period.
    Read more...